Technology | Flat Panel Displays | November 02, 2016

Eizo Releases 5 Megapixel RadiForce GX550 Medical Monitor for Breast Tomosynthesis

Sharpness Recovery technology restores image quality typically lost with increased monitor brightness

Eizo, RadiForce GX550 medical monitor, FDA approval, digital breast tomosynthesis, DBT, mammography, RSNA 2016

November 2, 2016 — Eizo Inc. announced the release of the RadiForce GX550, a 21.3-inch, 5 megapixel monitor for viewing detailed digital breast tomosynthesis and mammography images. It is the successor model to the RadiForce GX540 and features superior imaging capability and ease-of-use.

A medical monitor needs to be capable of high brightness in order to meet performance standards. However, in order to achieve high brightness in an LCD panel, the pixel aperture ratio has to be increased. This causes a typically unavoidable decline in sharpness. The RadiForce GX550 features Eizo’s Sharpness Recovery technology, with which the decrease in sharpness (MTF) is restored. This allows healthcare professionals to display an image safely on the monitor that is true to the original source data, even at high brightness levels.

The monitor’s new design features thinner, black front bezels, making it easier to focus on images in dark reading rooms, while the original white stripe design around the sides of the monitor presents a fresh, clean aesthetic to promote a comfortable, user-friendly environment. For keeping the workspace efficient, the monitor’s width, height and depth were reduced by 21 mm, 36 mm and 45.5 mm respectively – a 28 percent difference compared to its predecessor. The width of the side bezels was reduced by approximately half to 13.5 mm – the thinnest in the industry for 5 megapixel monitors, according to Eizo. This allows users to comfortably view two monitors side by side to compare images.

The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for digital breast tomosynthesis and digital mammography for the RadiForce GX550. Digital breast tomosynthesis is a method of breast screening that allows the radiologist to view detailed three-dimensional images of the breast assembled from multiple X-ray pictures. When used in combination with digital mammography, tomosynthesis provides radiologists with multiple screening techniques that can be utilized together for increased diagnostic precision in breast cancer detection.

Eizo will be showing the RadiForce GX550 at the 2016 Radiological Society of North America annual meeting (RSNA 2016), Nov. 27-Dec. 1 in Chicago.

The new monitor will begin shipping in December.

For more information: www.eizo.com

Related Content

Sponsored Content | Videos | Flat Panel Displays | February 19, 2020
EIZO medical monitors were showcased recently at RSN...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...